Southeast Nebraska Oncology Cancer Center — Lincoln, Nebraska

Southeast Nebraska Oncology Cancer Center is a clinical research site located in Lincoln, Nebraska, United States 68510.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Southeast Nebraska Oncology Cancer Center has participated in 4 clinical trials.

Therapeutic areas: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis, Tumor Pathway Activations Inhibited by Dovitinib.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lincoln

Browse all research sites in Nebraska · View every site in Lincoln

• Lincoln Division VA Nebraska Western IA HCS
• University of Nebraska-Lincoln
• [online program, administered by the University of Nebraska-Lincoln]
• St. Elizabeth's Hospital
• Nebraska Heart Institute Heart Hospital
• University of Nebraska, College of Dentistry
• University of Nebraska Medical Center, College of Nursing
• Madonna Rehabilitation Hospital Institute for Rehabilitation Science and Engineering
• University of Nebraska
• University of Nebraska Medical Center College of Dentistry
• CHI St Elizabeth Hospital
• Bryan Lincoln General Hospital

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Southeast Nebraska Oncology Cancer Center?

Southeast Nebraska Oncology Cancer Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Southeast Nebraska Oncology Cancer Center conducted?

Southeast Nebraska Oncology Cancer Center has 4 clinical trials on record. Their work covers First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis, Tumor Pathway Activations Inhibited by Dovitinib.

Is Southeast Nebraska Oncology Cancer Center accredited by Crixeo Clinical Trials?

Southeast Nebraska Oncology Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Southeast Nebraska Oncology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.